Find your next paid study

Intra-Cellular Therapies, Inc.NCT06229210

Depressive Disorder, Major

A Double-blind, Randomized, Psychoactive Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine 84 mg in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder in Adolescent Participants With Acute Suicidal Ideation or Behavior

The purpose of this study is to evaluate how well JNJ-54135419 works (efficacy) in addition to comprehensive standard of care (SoC) in rapidly reducing the sym…

Janssen Research & Development, LLCNCT07227454

DementiaPostoperative Delirium (POD)Postoperative Neurocognitive Disorder+3 more

Real-world and Innovative Multimodal Prediction and Prevention of Postoperative Mortality and Multi-morbidities

This study will contribute to creating a prospective and automated preoperative risk assessment algorithm for predicting 30-day mortality, major adverse cardia…

University of PittsburghNCT06042413

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

The goal of this clinical trial is to learn if a drug called TNX-102 SL works to treat moderate to severe major depressive disorder in adults. It will also lea…

Major Depressive Episode (MDE)Major Depressive Disorder (MDD)Depression

Tonix Pharmaceuticals, Inc.NCT07621237

An Observational Study of the Developing Brain, Impulsivity and Compulsivity

Background: Impulsivity is acting 'without thinking.' Compulsivity is being overly inflexible. People vary in how impulsive or compulsive they are. Extreme ve…

Typical DevelopmentObsessive Compulsive DisorderConduct Disorder+2 more

National Institute of Mental Health (NIMH)NCT04631042

~$10 – $675

Sleep DeprivationCritical IllnessSleep-Wake Disorders+3 more

Comparing Two Multicomponent ICU Bundles To Promote Sleep and Reduce Delirium in Critically Ill Adults

SHANTI-ICU compares the effectiveness of two evidence-based multicomponent ICU sleep promotion bundles on delirium and patient-reported sleep quality in critic…

University of California, San DiegoNCT07840560

Irritability Associated With Autism Spectrum Disorder

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Lumateperone in the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients 5 to 17 Years of Age

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability ass…

Intra-Cellular Therapies, Inc.NCT06690398

Irritability Associated With Autism Spectrum Disorder

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Lumateperone in the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients 5 to 17 Years of Age

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability ass…

Intra-Cellular Therapies, Inc.NCT06706674

Depressive Disorder, Major

A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-(Milligram) mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms

The purpose of this study is to know how well seltorexant works, and also to evaluate safety and maintenance effect of seltorexant compared with placebo as an …

Janssen Research & Development, LLCNCT06559306

Opioid Abuse (Disorder)Clinical Decision Support

Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3

This study is stage 2, round 3 of a larger study which refines and optimizes the EMBED clinical decision support (CDS) to increase number of ED physicians foll…

Yale UniversityNCT07793383

Phase 4

Anomalous Motor System Physiology in Attention Deficit Hyperactivity Disorder: Biomarker Validation and Modeling Domains of Function

Attention-Deficit/Hyperactivity Disorder (ADHD) is the most commonly diagnosed neurobehavioral disorder in childhood. Children with ADHD struggle in school due…

Attention Deficit Hyperactivity Disorder Combined

Donald Gilbert, MD, MS, FAAN, FAAPNCT04421248

~$10 – $7,500

Opioid Use DisorderMajor Depressive Disorder (MDD)

Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation

This study will compare transcranial magnetic stimulation (TMS) with sham TMS in people with opioid use disorder who are taking buprenorphine and have major de…